{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:59:15Z","timestamp":1777906755275,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005229","name":"Key Science and Technology Foundation of Gansu Province","doi-asserted-by":"publisher","award":["21JR7RA435"],"award-info":[{"award-number":["21JR7RA435"]}],"id":[{"id":"10.13039\/501100005229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360029"],"award-info":[{"award-number":["82360029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.yexcr.2025.114454","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T16:48:49Z","timestamp":1739638129000},"page":"114454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Threonine and tyrosine kinase promotes multiple myeloma progression by regulating regucalcin expression"],"prefix":"10.1016","volume":"446","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5873-3862","authenticated-orcid":false,"given":"Xiaofeng","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuxi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianning","family":"Di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YanHong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4170-1113","authenticated-orcid":false,"given":"Liansheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2025.114454_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrclinonc.2011.63","article-title":"Treatment of multiple myeloma","volume":"8","author":"Rajkumar","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2025.114454_bib2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2025.114454_bib3","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(14)60493-1","article-title":"Multiple myeloma","volume":"385","author":"R\u00f6llig","year":"2015","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.yexcr.2025.114454_bib4","first-page":"70442","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.yexcr.2025.114454_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2025.114454_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bjh.15210","article-title":"Resistance to proteasome inhibitors and other targeted therapies in myeloma","volume":"182","author":"Wallington-Beddoe","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yexcr.2025.114454_bib7","first-page":"373","article-title":"Multiple myeloma: diagnosis and treatment","volume":"95","author":"Michels","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.yexcr.2025.114454_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4161\/cc.3.4.784","article-title":"A field guide to the Mps1 family of protein kinases","volume":"3","author":"Fisk","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.yexcr.2025.114454_bib9","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180109","article-title":"Leader of the SAC: molecular mechanisms of Mps1\/TTK regulation in mitosis","volume":"8","author":"Pachis","year":"2018","journal-title":"Open Biol"},{"key":"10.1016\/j.yexcr.2025.114454_bib10","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/jnci\/djt168","article-title":"Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs","volume":"105","author":"Tannous","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.yexcr.2025.114454_bib11","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1073\/pnas.1007645108","article-title":"High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells","volume":"108","author":"Daniel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2025.114454_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1479-5876-9-153","article-title":"Cancer\/Testis Antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy","volume":"9","author":"Shiraishi","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.yexcr.2025.114454_bib13","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/bjc.2014.460","article-title":"Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells","volume":"111","author":"Kaistha","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2025.114454_bib14","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/1541-7786.MCR-14-0462-T","article-title":"Targeting MPS1 enhances radiosensitization of human glioblastoma by modulating DNA repair proteins","volume":"13","author":"Maachani","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114454_bib15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.molonc.2013.12.018","article-title":"TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers","volume":"8","author":"Gy\u0151rffy","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.yexcr.2025.114454_bib16","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.3748\/wjg.v23.i31.5787","article-title":"Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer","volume":"23","author":"Xie","year":"2017","journal-title":"WJG"},{"key":"10.1016\/j.yexcr.2025.114454_bib17","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3324\/haematol.2018.208306","article-title":"Kinome expression profiling to target new therapeutic avenues in multiple myeloma","volume":"105","author":"de Boussac","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.yexcr.2025.114454_bib18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3324\/haematol.2023.282838","article-title":"TTK\/MPS1 inhibitor OSU-13 targets the mitotic checkpoint and is a potential therapeutic strategy for myeloma","volume":"109","author":"Longo","year":"2023","journal-title":"Haematol."},{"key":"10.1016\/j.yexcr.2025.114454_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.6004\/jnccn.2020.0057","article-title":"Multiple myeloma, version 3.2021, NCCN clinical practice guidelines in oncology","volume":"18","author":"Kumar","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.yexcr.2025.114454_bib20","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2025.114454_bib21","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A monoclonal gammopathy precedes multiple myeloma in most patients","volume":"113","author":"Weiss","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2025.114454_bib22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2025.114454_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2025.114454_bib24","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma","volume":"356","author":"Kyle","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2025.114454_bib25","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1038\/s41375-020-0921-y","article-title":"Genome instability in multiple myeloma","volume":"34","author":"Neuse","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.yexcr.2025.114454_bib26","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.3390\/ijms21145002","article-title":"Cytokine-mediated dysregulation of signaling pathways in the pathogenesis of multiple myeloma","volume":"21","author":"Akhtar","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.yexcr.2025.114454_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.999939","article-title":"The role of the bone microenvironment in regulating myeloma residual disease and treatment","volume":"12","author":"Dadzie","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2025.114454_bib28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.canlet.2017.11.020","article-title":"Targeting signaling pathways in multiple myeloma: pathogenesis and implication for treatments","volume":"414","author":"Hu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2025.114454_bib29","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1083\/jcb.200904020","article-title":"Loss of spindle assembly checkpoint-mediated inhibition of Cdc20 promotes tumorigenesis in mice","volume":"185","author":"Li","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexcr.2025.114454_bib30","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-17-0342","article-title":"TTK inhibitors as a targeted therapy for CTNNB1 (\u03b2-catenin) mutant cancers","volume":"16","author":"Zaman","year":"2017","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.yexcr.2025.114454_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01322338","article-title":"Genomic cloning and chromosomal assignment of rat regucalcin gene","volume":"151","author":"Shimokawa","year":"1995","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.yexcr.2025.114454_bib32","first-page":"371","article-title":"Role of regucalcin in maintaining cell homeostasis and function","volume":"15","author":"Yamaguchi","year":"2005","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.yexcr.2025.114454_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11010-011-0779-4","article-title":"Regucalcin and cell regulation: role as a suppressor protein in signal transduction","volume":"353","author":"Yamaguchi","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.yexcr.2025.114454_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00441-013-1665-z","article-title":"Role of regucalcin in cell nuclear regulation: involvement as a transcription factor","volume":"354","author":"Yamaguchi","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.yexcr.2025.114454_bib35","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s10495-013-0859-x","article-title":"The anti-apoptotic effect of regucalcin is mediated through multisignaling pathways","volume":"18","author":"Yamaguchi","year":"2013","journal-title":"Apoptosis"},{"key":"10.1016\/j.yexcr.2025.114454_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/cpr.12036","article-title":"Suppressive role of regucalcin in liver cell proliferation: involvement in carcinogenesis","volume":"46","author":"Yamaguchi","year":"2013","journal-title":"Cell Prolif."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725000503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725000503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:23:03Z","timestamp":1777641783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482725000503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0014482725000503"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114454","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Threonine and tyrosine kinase promotes multiple myeloma progression by regulating regucalcin expression","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114454"}}